DE68915987T2 - Diätomares Jod zur Behandlung von Jodmangelkrankheiten. - Google Patents

Diätomares Jod zur Behandlung von Jodmangelkrankheiten.

Info

Publication number
DE68915987T2
DE68915987T2 DE68915987T DE68915987T DE68915987T2 DE 68915987 T2 DE68915987 T2 DE 68915987T2 DE 68915987 T DE68915987 T DE 68915987T DE 68915987 T DE68915987 T DE 68915987T DE 68915987 T2 DE68915987 T2 DE 68915987T2
Authority
DE
Germany
Prior art keywords
iodine
treatment
composition
deficiency diseases
dietary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68915987T
Other languages
English (en)
Other versions
DE68915987D1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
943038 ONTARIO Inc KINGSTON ONTARIO CA
ESKIN BERNARD A DR PHILADELPHIA PA US
Original Assignee
943038 ONTARIO Inc KINGSTON ONTARIO CA
ESKIN BERNARD A DR PHILADELPHIA PA US
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 943038 ONTARIO Inc KINGSTON ONTARIO CA, ESKIN BERNARD A DR PHILADELPHIA PA US filed Critical 943038 ONTARIO Inc KINGSTON ONTARIO CA
Application granted granted Critical
Publication of DE68915987D1 publication Critical patent/DE68915987D1/de
Publication of DE68915987T2 publication Critical patent/DE68915987T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE68915987T 1989-01-03 1989-01-10 Diätomares Jod zur Behandlung von Jodmangelkrankheiten. Expired - Fee Related DE68915987T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/292,968 US5171582A (en) 1985-07-31 1989-01-03 Treatment of iodine deficiency diseases

Publications (2)

Publication Number Publication Date
DE68915987D1 DE68915987D1 (de) 1994-07-14
DE68915987T2 true DE68915987T2 (de) 1995-01-12

Family

ID=23127029

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68915987T Expired - Fee Related DE68915987T2 (de) 1989-01-03 1989-01-10 Diätomares Jod zur Behandlung von Jodmangelkrankheiten.

Country Status (14)

Country Link
US (1) US5171582A (de)
EP (1) EP0377266B1 (de)
JP (1) JP2994741B2 (de)
AT (1) ATE106738T1 (de)
AU (1) AU639222B2 (de)
BG (1) BG94738A (de)
BR (1) BR9006990A (de)
CA (1) CA1336889C (de)
DE (1) DE68915987T2 (de)
DK (1) DK128291A (de)
ES (1) ES2057098T3 (de)
HU (1) HUT57050A (de)
MC (1) MC2172A1 (de)
WO (1) WO1990007339A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250304A (en) * 1985-07-31 1993-10-05 Ghent William R Treatment of iodine deficiency diseases
US6019970A (en) * 1985-07-31 2000-02-01 Ghent William R. Treatment of iodine deficiency diseases
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases
US5910318A (en) * 1991-03-28 1999-06-08 943038 Ontario Inc. Treatment of iodine deficiency diseases
DK0609217T3 (da) * 1991-03-28 1998-03-30 Ontario Inc 943038 Tørre farmaceutiske stivelse-iod-formuleringer
US5955101A (en) * 1991-03-28 1999-09-21 943038 Ontario Inc. Dry starch-iodine pharmaceutical formulations
US5554600A (en) * 1995-01-20 1996-09-10 Eli Lilly And Company Methods for inhibiting endometriosis
US5489587A (en) * 1995-01-20 1996-02-06 Eli Lilly And Company Benzofurans used to inhibit bone loss
EP0722727A1 (de) * 1995-01-20 1996-07-24 Eli Lilly And Company Benzofuran-Derivate zur Hemmung der uterinem Fibrose
US6238644B1 (en) 1997-09-03 2001-05-29 Wayne State University Method for treating and/or imaging breast cancer using radioactive iodide
US5885592A (en) * 1997-10-29 1999-03-23 Symbollon Corporation Methods and pharmaceutical compositions for oral delivery of molecular iodine
WO2006017939A1 (en) * 2004-08-20 2006-02-23 Dennis Hardy O'dowd Method of detecting and treating allogenic cells responsible for endometriosis
US9511151B2 (en) 2010-11-12 2016-12-06 Uti Limited Partnership Compositions and methods for the prevention and treatment of cancer
US10988516B2 (en) 2012-03-26 2021-04-27 Uti Limited Partnership Methods and compositions for treating inflammation
US9603948B2 (en) 2012-10-11 2017-03-28 Uti Limited Partnership Methods and compositions for treating multiple sclerosis and related disorders
ES2730273T3 (es) 2013-11-04 2019-11-11 Uti Lp Métodos y composiciones para inmunoterapia sostenida
EP3291832A4 (de) 2015-05-06 2018-09-12 UTI Limited Partnership Nanopartikelzusammensetzungen zur verzögerten therapie

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384960A (en) * 1979-11-13 1983-05-24 Polley R D Iodine dispenser and method of dispensing iodine
US4816255A (en) * 1985-07-31 1989-03-28 Ghent William R Treatment of iodine deficiency breast syndrome
FR2611733B1 (fr) * 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition a base de gomme diorganopolysiloxane contenant de l'iode pour le traitement des eaux

Also Published As

Publication number Publication date
WO1990007339A1 (en) 1990-07-12
JP2994741B2 (ja) 1999-12-27
ES2057098T3 (es) 1994-10-16
HUT57050A (en) 1991-11-28
BR9006990A (pt) 1991-11-12
ATE106738T1 (de) 1994-06-15
DK128291A (da) 1991-08-21
EP0377266A1 (de) 1990-07-11
US5171582A (en) 1992-12-15
MC2172A1 (fr) 1992-05-22
AU639222B2 (en) 1993-07-22
HU900916D0 (en) 1991-10-28
BG94738A (bg) 1993-12-24
CA1336889C (en) 1995-09-05
EP0377266B1 (de) 1994-06-08
DE68915987D1 (de) 1994-07-14
AU4819990A (en) 1990-08-01
DK128291D0 (da) 1991-07-01
JPH04503949A (ja) 1992-07-16

Similar Documents

Publication Publication Date Title
DE68915987T2 (de) Diätomares Jod zur Behandlung von Jodmangelkrankheiten.
NZ224231A (en) Gels containing metal chlorite as disinfectant
DE69514794T2 (de) Sublinguale dosierungsformen enthaltend apomorphin zur verwendung bei der behandlung von erektiler dysfunktion
SE8005580L (sv) Harvextkomposition och forfarande for dess framstellning
DE3267352D1 (en) Novel aroylimidazolones
DK157724C (da) Dipeptidsoedemiddel-metal-kompleks og dets anvendelse
DE69109401D1 (de) Wässrige Zusammensetzungen zur Behandlung von porösen Substraten.
FR2442250A1 (fr) Compositions de verre et ciments auxquels sont incorporees ces compositions
DE69000510T2 (de) Zusammensetzung fuer die behandlung von wasser oder waesserigen systemen.
EP0136569A3 (de) Isoflavon-Derivate, ihre Herstellung und Verwendung
DE69010294D1 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
ES8304919A1 (es) Un procedimiento para la preparacion de dicloroamino-acidos.
GR960300006T1 (en) Alkaloids from mappia foetida, the use thereof and formulations containing them.
RO79426B1 (ro) Compozitie medicamentoasa pentru tratamentul unor neuroviroze
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
NO912528L (no) Behandling av sykdommer forbundet med jodmangel.
RU95118260A (ru) Способ получения металлической ртути из продуктов, содержащих хлорид ртути
DE3775278D1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
ES468435A1 (es) Procedimiento para la precipitacion y separacion del arseni-co de soluciones que contienen cobre
DE69012687T2 (de) Metallschützende Zusammensetzungen, ihr Herstellungsverfahren und Metallschutzverfahren.
GB2009231A (en) Malting process
IT1240747B (it) Composizioni farmaceutiche ad attivita' riduttrice di radicali ossigeno e loro preparazione
ES8702484A1 (es) Un metodo de secuestrar o complejar iones metalicos en una solucion acuosa.

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Free format text: ERFINDER WIRD SPAETER GENANNT WERDEN

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee